BioSpace News Archive

Biotech Bay

Rani Therapeutics to Present at the 2023 Jefferies Healthcare Conference

Rani Therapeutics Holdings, Inc. announced the company’s Chief Executive Officer, Talat Imran, and Chief Financial Officer, Svai Sanford, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023 from 4:00-4:25 pm E.T. in Track 3.

June 1, 2023
·
1 min read
Genetown

Solid Biosciences to Participate at the 2023 Jefferies Healthcare Conference

Solid Biosciences Inc. announced that Bo Cumbo, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 3:00 PM ET.

June 1, 2023
·
1 min read
BioCapital

Gain Therapeutics to Present at the 2023 Jefferies Healthcare Conference

Gain Therapeutics, Inc. announced that Matthias Alder, Chief Executive Officer, will present at the Jefferies Healthcare Conference, taking place June 7-9 in New York, NY.

June 1, 2023
·
1 min read
Pharm Country

Eyenovia Announces Presentation at the OCTANE Ophthalmology Tech Forum 2023

Eyenovia, Inc. announced that the company will be delivering a presentation at the annual OCTANE Ophthalmology Tech Forum 2023, which is being held June 8-9 in Newport Beach, CA.

June 1, 2023
·
5 min read
Genetown

Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split

Angion Biomedia Corp., a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10.

June 1, 2023
·
2 min read
Pharm Country

Orchestra BioMed to Present at the 2023 Jefferies Global Healthcare Conference

Orchestra BioMed Holdings, Inc. announced that company management will present and be available for one-on-one meetings at the Jefferies Global Healthcare Conference being held in New York, NY, June 7-9, 2023.

June 1, 2023
·
4 min read
Genetown

Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Coverage by Taglich Brothers with a Share Price Target of $20.

Ocean Biomedical, Inc. announced that an equity analyst coverage report has been issued by Taglich Brothers with a price target of $20 per share.

June 1, 2023
·
7 min read
Drug Development

NeuroTrauma Sciences Commences First-in-Human Dosing in the US of Investigational Neuroprotective Drug NTS-104

NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing neuroprotective therapeutics for treating patients with stroke and other CNS injuries, today announced that it has commenced dosing in a Phase 1 study of its investigational drug NTS-104, in healthy volunteers.

June 1, 2023
·
2 min read
BioForest

The Max Foundation to Launch Treatment Access for Advanced Breast Cancer in Nine Countries Across Africa, Latin America, and South Asia in Q3 2023

The Max Foundation announced the launch of its Max Access Solutions program to deliver access to treatment for HR+/HER2- advanced breast cancer patients in collaboration with leading oncologists in low and middle-income countries.

June 1, 2023
·
6 min read
Pharm Country

GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US

GSK plc announced the launch of the COiMMUNITY Initiative to help reduce health inequities and set a new precedent for adult immunization rates in the US, which continue to remain below pre-pandemic levelsi.

June 1, 2023
·
7 min read